<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T07:07:12Z</responseDate>
  <request identifier="oai:figshare.com:article/32805743" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32805743</identifier>
        <datestamp>2026-10-01T16:13:35Z</datestamp>
        <setSpec>portal_1172</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Identification and functional study of peptides from the skin secretion of Phyllomedusa azurea</dc:title>
          <dc:creator>Zehao Li (3807931)</dc:creator>
          <dc:subject>PUREID: 688011572</dc:subject>
          <dc:subject>Antimicrobial peptides</dc:subject>
          <dc:subject>peptide modification</dc:subject>
          <dc:subject>protease resistance</dc:subject>
          <dc:subject>dermaseptin</dc:subject>
          <dc:subject>phylloseptin</dc:subject>
          <dc:description>Antimicrobial peptides (AMPs) from Phyllomedusa frog skin secretions represent a rich source of membrane-active anti-infective agents. In this work, three major AMP lineages, dermaseptins (QUB-2480, DRS-01) and phylloseptins (PS-12), were comprehensively-investigated alongside rationally-designed analogue libraries to elucidate the structural determinants governing antimicrobial, cytotoxic, enzymatic, and biophysical properties. All peptides and analogues were chemically-synthesised and structurally-validated by RP-HPLC, ESI-MS, and circular dichroism spectroscopy, confirming amphipathic α-helical conformations under membrane-mimetic conditions.&lt;br&gt;&lt;br&gt;QUB-2480, a newly identified dermaseptin from Phyllomedusa azurea, displayed potent broad-spectrum antibacterial activity, with MIC values in the low micromolar range against both Gram-positive and Gram-negative bacteria，particularly against Gram-negative bacteria. Analogues with enhanced cationicity apparently improved potency and therapeutic indices, whereas reduced hydrophobicity or loss of C-terminal amidation attenuated activity. PS-12 displayed moderate antibacterial activity, with MIC values ranging from 2–64 µM across tested strains. Rational modification of cationicity and α-helical propensity generated more potent analogues, with PS-12-1 showing improved activity (MIC = 1–4 µM against S. aureus and E. coli). However, excessive hydrophobicity or structural disruption reduced selectivity. Hydrocarbon stapling (PS-12-5) enhanced resistance to proteolytic degradation but resulted in reduced antimicrobial potency (MIC ≥64 µM), highlighting a trade-off between stability and activity. For the dermaseptin DRS-01, activity was robust across bacterial species but markedly-compromised by trypsin digestion, whereas the N-terminal Nal-modified analogue DRS-N preserved both potency and partial protease resistance. Modifications aimed at sequence shortening or charge redistribution generated apparent loss of activity.&lt;br&gt;&lt;br&gt;Across all peptide families, mechanistic assays demonstrated rapid bactericidal effects mediated by membrane perturbation, including outer- and inner-membrane permeabilisation, depolarisation, and time-dependent disruption consistent with a carpet-like mode of action. Several analogues exhibited reduced haemolytic activity and improved antiproliferative effects against cancer cell lines, underscoring the tunability of bioactivity profiles. Resistance-development assays revealed minimal MIC shifts over serial passaging, indicating a low propensity for resistance induction.&lt;br&gt;&lt;br&gt;Collectively, these studies have established QUB-2480, PS-12, DRS-01, and their optimised analogues, as promising membrane-active AMPs, and provide detailed structure–activity insights to guide the rational design of next-generation antimicrobial therapeutics with improved stability, potency, and safety.&lt;br&gt;&lt;br&gt;&lt;i&gt;Thesis is embaragoed until 31 July 2031.&lt;/i&gt;</dc:description>
          <dc:date>2026-10-01T16:13:35Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10.17034/32805743.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/Identification_and_functional_study_of_peptides_from_the_skin_secretion_of_Phyllomedusa_azurea/32805743</dc:relation>
          <dc:rights>All Rights Reserved</dc:rights>
          <dc:rights>Open Access after 2031-07-31</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
